Temple University Health System’s preparations for and treatment of patients amidst the coronavirus pandemic continue to be part of the media’s COVID-19 coverage.
- Tony S. Reed, MD, PhD, MBA, Executive Vice President and Chief Medical Officer of Temple University Health System, spoke with WHYY about the Health Resources and Services Administration (HRSA) funding that will no longer be available come April 6 for COVID-19 vaccine reimbursement for those who are uninsured. The reimbursement for COVID-19 testing ended on March 22. The Philadelphia Tribune picked up the WHYY article.
- In new research published in the journal JCI Insight, scientists at the Lewis Katz School of Medicine at Temple University show that responses to the Pfizer-BioNTech mRNA vaccine differ significantly in individuals based on whether or not they were previously infected with COVID-19. Steven G. Kelsen, MD, Professor in the Department of Thoracic Medicine and Surgery at the Katz School of Medicine, is first author on the report. Multiple media outlets, including Medical Xpress, ScienceDaily and Technology Networks, highlighted the research.